s6y
Company name or ticker
Search
Prelude Therapeutics Inc
SCHEDULE 13G
Filing
Filed
Wednesday, July 8, 2026
Accession number
0001213900-26-076456
Documents
primary_doc.xml
SCHEDULE 13G
JOINT FILING AGREEMENT
EX-99.A
On sec.gov
Filing index
All files
Complete submission text
SGML header